Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and ...
A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. | A phase 2a trial of NMD ...
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products ...
The American will miss AC Milan's trip to Bologna Tuesday, with a bursitis complaint the latest in a succession of minor ...
Leede Financial analyst Douglas Loe has initiated coverage of Satellos Biosciences with a “Speculative Buy” rating and a ...
Jesy Nelson has revealed the heartbreaking reason behind her split from fiancé Zion Foster, just four months after their engagement.
Detailed price information for Generation Bio Co. (GBIO-Q) from The Globe and Mail including charting and trades.
Jesy Nelson has opened up about the heartbreaking reality of her 'intense' daily life since her twin daughters were diagnosed ...
The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the ...
Garaherb Unveiled offers a fact-based 2026 overview of the Garaherb male supplement, including ingredients, safety, usage, ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results